SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 134 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $364,000 | +67.0% | 27,600 | +22.7% | 0.00% | +33.3% |
| Q1 2016 | $218,000 | -7.2% | 22,500 | -12.1% | 0.00% | 0.0% |
| Q4 2015 | $235,000 | +35.1% | 25,600 | +2.0% | 0.00% | +50.0% |
| Q3 2015 | $174,000 | -28.1% | 25,100 | +2.0% | 0.00% | -33.3% |
| Q2 2015 | $242,000 | +15.8% | 24,600 | +4.2% | 0.00% | 0.0% |
| Q1 2015 | $209,000 | -12.6% | 23,600 | -14.5% | 0.00% | 0.0% |
| Q4 2014 | $239,000 | +15.5% | 27,600 | -8.3% | 0.00% | 0.0% |
| Q3 2014 | $207,000 | +32.7% | 30,100 | +1.7% | 0.00% | +50.0% |
| Q2 2014 | $156,000 | +3.3% | 29,600 | -10.6% | 0.00% | 0.0% |
| Q1 2014 | $151,000 | -5.0% | 33,100 | +6.4% | 0.00% | -33.3% |
| Q4 2013 | $159,000 | +3.9% | 31,100 | +3.3% | 0.00% | 0.0% |
| Q3 2013 | $153,000 | – | 30,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |